SEARCH

SEARCH BY CITATION

References

  • Athale, U.H., Razzouk, B.I., Raimondi, S.C., Tong, X., Behm, F.G., Head, D.R., Srivastava, D.K., Rubnitz, J.E., Bowman, L., Pui, C.H. & Ribeiro, R.C. (2001) Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution’s experience. Blood, 97, 37273732.
  • Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1985) Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Annals of Internal Medicine, 103, 460462.
  • Bernstein, J., Dastugue, N., Haas, O.A., Harbott, J., Heerema, N.A., Huret, J.L., Landman-Parker, J., LeBeau, M.M., Leonard, C., Mann, G., Pages, M.P., Perot, C., Pirc-Danoewinata, H., Roitzheim, B., Rubin, C.M., Slociak, M. & Viguie, F. (2000) Nineteen cases of the t(1;22)(p13;q13) acute megakaryblastic leukaemia of infants/children and a review of 39 cases: report from a t(1;22) study group. Leukemia, 14, 216218.
  • Bourquin, J.P., Subramanian, A., Langebrake, C., Reinhardt, D., Bernard, O., Ballerini, P., Baruchel, A., Cave, H., Dastugue, N., Hasle, H., Kaspers, G.L., Lessard, M., Michaux, L., Vyas, P., Van Wering, E., Zwaan, C.M., Golub, T.R. & Orkin, S.H. (2006) Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling. Proceedings of the National Academy of Sciences of the United States of America, 103, 33393344.
  • Carroll, A., Civin, C., Schneider, N., Dahl, G., Pappo, A., Bowman, P., Emami, A., Gross, S., Alvarado, C., Phillips, C., Krischer, J., Crist, W., Head, D., Gresik, M., Ravindranath, Y. & Weinstein, H. (1991) The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study. Blood, 78, 748752.
  • Creutzig, U., Harbott, J., Sperling, C., Ritter, J., Zimmermann, M., Loffler, H., Riehm, H., Schellong, G. & Ludwig, W.D. (1995) Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood, 86, 30973108.
  • Creutzig, U., Ritter, J., Vormoor, J., Ludwig, W.D., Niemeyer, C., Reinisch, I., Stollmann-Gibbels, B., Zimmermann, M. & Harbott, J. (1996) Myelodysplasia and acute myelogenous leukemia in Down’s syndrome. A report of 40 children of the AML-BFM Study Group. Leukemia, 10, 16771686.
  • Creutzig, U., Reinhardt, D., Diekamp, S., Dworzak, M., Stary, J. & Zimmermann, M. (2005) AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. Leukemia, 19, 13551360.
  • Dastugue, N., Lafage-Pochitaloff, M., Pages, M.P., Radford, I., Bastard, C., Talmant, P., Mozziconacci, M.J., Leonard, C., Bilhou-Nabera, C., Cabrol, C., Capodano, A.M., Cornillet-Lefebvre, P., Lessard, M., Mugneret, F., Perot, C., Taviaux, S., Fenneteaux, O., Duchayne, E. & Berger, R. (2002) Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Blood, 100, 618626.
  • Duchayne, E., Fenneteau, O., Pages, M.P., Sainty, D., Arnoulet, C., Dastugue, N., Garand, R. & Flandrin, G. (2003) Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Francais d’Hematologie Cellulaire (GFHC). Leukaemia & Lymphoma, 44, 4958.
  • Gamis, A.S. (2005) Acute myeloid leukemia and Down syndrome evolution of modern therapy–state of the art review. Pediatric Blood Cancer, 44, 1320.
  • Gamis, A.S., Woods, W.G., Alonzo, T.A., Buxton, A., Lange, B., Barnard, D.R., Gold, S. & Smith, F.O. (2003) Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children’s Cancer Group Study 2891. Journal of Clinical Oncology, 21, 34153422.
  • Garderet, L., Labopin, M., Gorin, N.C., Polge, E., Baruchel, A., Meloni, G., Ortega, J., Vossen, J., Bunjes, D., Leverger, G., Blaise, D., Ferrant, A., Brune, M., Dore, E., Gadner, H., Zintl, F., Yaniv, I., Dini, G. & Frassoni, F. (2005) Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT). Blood, 105, 405409.
  • Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. Journal of Clinical Oncology, 17, 38353849.
  • Hirose, Y., Kudo, K., Kiyoi, H., Hayashi, Y., Naoe, T. & Kojima, S. (2003) Comprehensive analysis of gene alterations in acute megakaryoblastic leukemia of Down’s syndrome. Leukemia, 17, 22502252.
  • Imashuku, S., Hibi, S., Sako, M., Lin, Y.W., Ikuta, K., Nakata, Y., Mori, T., Iizuka, S., Horibe, K. & Tsunematsu, Y. (2000) Hemophagocytosis by leukemic blasts in 7 acute myeloid leukemia cases with t(16;21)(p11;q22): common morphologic characteristics for this type of leukemia. Cancer, 88, 19701975.
  • Ito, E., Kasai, M., Hayashi, Y., Toki, T., Arai, K., Yokoyama, S., Kato, K., Tachibana, N., Yamamoto, M. & Yokoyama, M. (1995) Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down’s syndrome. British Journal Haematology, 90, 607614.
  • Kaplan, E. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457481.
  • Kita, K., Miwa, H., Nakase, K., Kawakami, K., Kobayashi, T., Shirakawa, S., Tanaka, I., Ohta, C., Tsutani, H., Oguma, S., Kyo, T., Dohy, H., Kamada, N., Nasu, K. & Uchino, H. (1993) Clinical importance of CD7 expression in acute myelocytic leukemia. The Japan Cooperative Group of Leukemia/Lymphoma. Blood, 81, 23992405.
  • Kojima, S., Matsuyama, T., Sato, T., Horibe, K., Konishi, S., Tsuchida, M., Hayashi, Y., Kigasawa, H., Akiyama, Y., Okamura, J., Nakahata, T., Bessho, F., Eguchi, M., Nakazawa, S. & Ueda, R. (1990) Down’s syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction. Blood, 76, 23482353.
  • Kojima, S., Kato, K., Matsuyama, T., Yoshikawa, T. & Horibe, K. (1993) Favorable treatment outcome in children with acute myeloid leukemia and Down syndrome. Blood, 81, 3164.
  • Kojima, S., Sako, M., Kato, K., Hosoi, G., Sato, T., Ohara, A., Koike, K., Okimoto, Y., Nishimura, S., Akiyama, Y., Yoshikawa, T., Ishii, E., Okamura, J., Yazaki, M., Hayashi, Y., Eguchi, M., Tsukimoto, I. & Ueda, K. (2000) An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down’s syndrome. Leukemia, 14, 786791.
  • Kong, X.T., Ida, K., Ichikawa, H., Shimizu, K., Ohki, M., Maseki, N., Kaneko, Y., Sako, M., Kobayashi, Y., Tojou, A., Miura, I., Kakuda, H., Funabiki, T., Horibe, K., Hamaguchi, H., Akiyama, Y., Bessho, F., Yanagisawa, M. & Hayashi, Y. (1997) Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood, 90, 11921199.
  • Lange, B.J., Kobrinsky, N., Barnard, D.R., Arthur, D.C., Buckley, J.D., Howells, W.B., Gold, S., Sanders, J., Neudorf, S., Smith, F.O. & Woods, W.G. (1998) Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children’s Cancer Group Studies 2861 and 2891. Blood, 91, 608615.
  • Levitt, G.A., Stiller, C.A. & Chessells, J.M. (1990) Prognosis of Down’s syndrome with acute leukaemia. Archives of Disease in Childhood, 65, 212216.
  • Lion, T., Haas, O.A., Harbott, J., Bannier, E., Ritterbach, J., Jankovic, M., Fink, F.M., Stojimirovic, A., Herrmann, J., Riehm, H.J., Lampert, F., Ritter, J., Koch, H. & Gadner, H. (1992) The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryocytic leukemia in young children. Blood, 79, 33253330.
  • Lu, G., Altman, A.J. & Benn, P.A. (1993) Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several? Cancer Genetics and Cytogenetics, 67, 8189.
  • Ma, Z., Morris, S.W., Valentine, V., Li, M., Herbrick, J.A., Cui, X., Bouman, D., Li, Y., Mehta, P.K., Nizetic, D., Kaneko, Y., Chan, G.C., Chan, L.C., Squire, J., Scherer, S.W. & Hitzler, J.K. (2001) Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nature Genetics, 28, 220221.
  • Mercher, T., Coniat, M.B., Monni, R., Mauchauffe, M., Nguyen Khac, F., Gressin, L., Mugneret, F., Leblanc, T., Dastugue, N., Berger, R. & Bernard, O.A. (2001) Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 98, 57765779.
  • Mercher, T., Busson-Le Coniat, M., Nguyen Khac, F., Ballerini, P., Mauchauffe, M., Bui, H., Pellegrino, B., Radford, I., Valensi, F., Mugneret, F., Dastugue, N., Bernard, O.A. & Berger, R. (2002) Recurrence of OTT-MAL fusion in t(1;22) of infant AML-M7. Genes, Chromosomes and Cancer, 33, 2228.
  • Paredes-Aguilera, R., Romero-Guzman, L., Lopez-Santiago, N. & Trejo, R.A. (2003) Biology, clinical, and hematologic features of acute megakaryoblastic leukemia in children. American Journal of Hematology, 73, 7180.
  • Rainis, L., Bercovich, D., Strehl, S., Teigler-Schlegel, A., Stark, B., Trka, J., Amariglio, N., Biondi, A., Muler, I., Rechavi, G., Kempski, H., Haas, O.A. & Izraeli, S. (2003) Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21. Blood, 102, 981986.
  • Rao, A., Hills, R.K., Stiller, C., Gibson, B.E., De Graaf, S.S., Hann, I.M., O’Marcaigh, A., Wheatley, K. & Webb, D.K. (2006) Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. British Journal Haematology, 132, 576583.
  • Ravindranath, Y., Abella, E., Krischer, J.P., Wiley, J., Inoue, S., Harris, M., Chauvenet, A., Alvarado, C.S., Dubowy, R., Ritchey, A.K., Land, V., Steuber, C.P. & Weinstein, H. (1992) Acute myeloid leukemia (AML) in Down’s syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood, 80, 22102214.
  • Reinhardt, D., Diekamp, S., Langebrake, C., Ritter, J., Stary, J., Dworzak, M., Schrauder, A., Zimmermann, M., Fleischhack, G., Ludwig, W.D., Harbott, J. & Creutzig, U. (2005) Acute megakaryoblastic leukemia in children and adolescents, excluding Down’s syndrome: improved outcome with intensified induction treatment. Leukemia, 19, 14951496.
  • Ribeiro, R.C., Oliveira, M.S., Fairclough, D., Hurwitz, C., Mirro, J., Behm, F.G., Head, D., Silva, M.L., Raimondi, S.C., Crist, W.M. & Krance, R. (1993) Acute megakaryoblastic leukemia in children and adolescents: a retrospective analysis of 24 cases. Leukaemia & Lymphoma, 10, 299306.
  • San Miguel, J.F., Gonzalez, M., Canizo, M.C., Ojeda, E., Orfao, A., Caballero, M.D., Moro, M.J., Fisac, P. & Lopez Borrasca, A. (1988) Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics. Blood, 72, 402407.
  • Shimada, A., Taki, T., Tabuchi, K., Tawa, A., Horibe, K., Tsuchida, M., Hanada, R., Tsukimoto, I. & Hayashi, Y. (2006) KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group. Blood, 107, 18061809.
  • Tallman, M.S., Neuberg, D., Bennett, J.M., Francois, C.J., Paietta, E., Wiernik, P.H., Dewald, G., Cassileth, P.A., Oken, M.M. & Rowe, J.M. (2000) Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood, 96, 24052411.
  • Taub, J.W., Huang, X., Matherly, L.H., Stout, M.L., Buck, S.A., Massey, G.V., Becton, D.L., Chang, M.N., Weinstein, H.J. & Ravindranath, Y. (1999) Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin. Blood, 94, 13931400.
  • Taub, J.W., Huang, X., Ge, Y., Dutcher, J.A., Stout, M.L., Mohammad, R.M., Ravindranath, Y. & Matherly, L.H. (2000) Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome. Cancer Research, 60, 64216426.
  • Wechsler, J., Greene, M., McDevitt, M.A., Anastasi, J., Karp, J.E., Le Beau, M.M. & Crispino, J.D. (2002) Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nature Genetics, 32, 148152.
  • Zeller, B., Gustafsson, G., Forestier, E., Abrahamsson, J., Clausen, N., Heldrup, J., Hovi, L., Jonmundsson, G., Lie, S.O., Glomstein, A. & Hasle, H. (2005) Acute leukaemia in children with Down syndrome: a population-based Nordic study. British Journal Haematology, 128, 797804.
  • Zipursky, A., Peeters, M. & Poon, A. (1987) Megakaryoblastic leukemia and Down’s syndrome: a review. Pediatric Hematology and Oncology, 4, 211230.